Trials / Unknown
UnknownNCT02871466
Stem Cells Therapy in Advanced Heart Failure
Intra Cardiac Autologous Stem Cells Infusion May Improve Clinical Outcomes in Failing Heart Subjects Refractory to Maximal Drug Therapy and Internal Cardioverter With a Defibrillator (ICD) Recipients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Campania Luigi Vanvitelli · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
stem cells therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, internal cardiovertor with a defibrillator (ICD) recipients, and a previous history of myocardial infarction and coronary artery revascularization. These patients, without indication to receive a cardiac resynchronization therapy (CRT), may have a worsening of heart failure, and symptoms of coronary artery disease. In this study we have evaluated in consecutive 30 selected patients the amelioration in failing heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, and associated to reduction of angina after a treatment with stem cells intra thoracic infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | stem cells infusion |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2022-01-01
- Completion
- 2022-07-01
- First posted
- 2016-08-18
- Last updated
- 2020-08-13
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02871466. Inclusion in this directory is not an endorsement.